FR2356425A1 - Application a titre de medicaments de derives organiques de la montmorillonite - Google Patents

Application a titre de medicaments de derives organiques de la montmorillonite

Info

Publication number
FR2356425A1
FR2356425A1 FR7620143A FR7620143A FR2356425A1 FR 2356425 A1 FR2356425 A1 FR 2356425A1 FR 7620143 A FR7620143 A FR 7620143A FR 7620143 A FR7620143 A FR 7620143A FR 2356425 A1 FR2356425 A1 FR 2356425A1
Authority
FR
France
Prior art keywords
montmorillonite
application
medicinal products
organic derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7620143A
Other languages
English (en)
Other versions
FR2356425B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7620143A priority Critical patent/FR2356425A1/fr
Priority to ZA00773747A priority patent/ZA773747B/xx
Priority to US05/810,678 priority patent/US4096278A/en
Priority to CA281,533A priority patent/CA1103154A/fr
Priority to NL7707263A priority patent/NL7707263A/xx
Priority to AU26615/77A priority patent/AU513829B2/en
Priority to BE178956A priority patent/BE856319A/fr
Priority to GB27708/77A priority patent/GB1564458A/en
Priority to DE19772729824 priority patent/DE2729824A1/de
Priority to JP7799477A priority patent/JPS536410A/ja
Publication of FR2356425A1 publication Critical patent/FR2356425A1/fr
Application granted granted Critical
Publication of FR2356425B1 publication Critical patent/FR2356425B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Abstract

Médicaments caractérisés en ce qu'ils sont constitués par les diméthyl-dialkylammonium-montmorillonites. Compositions pharmaceutiques renfermant des médicaments à titre de principe actif.
FR7620143A 1976-07-01 1976-07-01 Application a titre de medicaments de derives organiques de la montmorillonite Granted FR2356425A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR7620143A FR2356425A1 (fr) 1976-07-01 1976-07-01 Application a titre de medicaments de derives organiques de la montmorillonite
ZA00773747A ZA773747B (en) 1976-07-01 1977-06-22 Pharmaceutical compositions containing organic derivatives of montmorillonite
US05/810,678 US4096278A (en) 1976-07-01 1977-06-27 Organic derivatives of montmorillonite for treating lipid disturbances
CA281,533A CA1103154A (fr) 1976-07-01 1977-06-28 Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite
NL7707263A NL7707263A (nl) 1976-07-01 1977-06-30 Werkwijze voor het bereiden van een geneesmiddel en de onder toepassing van deze werkwijze verkregen gevormde geneesmiddelen.
AU26615/77A AU513829B2 (en) 1976-07-01 1977-06-30 Modified montmorillonite pharmaceutical
BE178956A BE856319A (fr) 1976-07-01 1977-06-30 Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite
GB27708/77A GB1564458A (en) 1976-07-01 1977-07-01 Pharmaceutical compositions containing montmorillonite derivatives
DE19772729824 DE2729824A1 (de) 1976-07-01 1977-07-01 Pharmazeutische zusammensetzungen mit organischen montmorillonit-derivaten und ihre herstellung
JP7799477A JPS536410A (en) 1976-07-01 1977-07-01 Medical composition containing organic derivative of montmorillonite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7620143A FR2356425A1 (fr) 1976-07-01 1976-07-01 Application a titre de medicaments de derives organiques de la montmorillonite

Publications (2)

Publication Number Publication Date
FR2356425A1 true FR2356425A1 (fr) 1978-01-27
FR2356425B1 FR2356425B1 (fr) 1978-12-15

Family

ID=9175127

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7620143A Granted FR2356425A1 (fr) 1976-07-01 1976-07-01 Application a titre de medicaments de derives organiques de la montmorillonite

Country Status (10)

Country Link
US (1) US4096278A (fr)
JP (1) JPS536410A (fr)
AU (1) AU513829B2 (fr)
BE (1) BE856319A (fr)
CA (1) CA1103154A (fr)
DE (1) DE2729824A1 (fr)
FR (1) FR2356425A1 (fr)
GB (1) GB1564458A (fr)
NL (1) NL7707263A (fr)
ZA (1) ZA773747B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2257173A1 (fr) * 2008-02-27 2010-12-08 Amcol International Corporation Procédés de traitement de troubles cardiovasculaires associés à une athérosclérose

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001401A1 (fr) * 1988-10-25 1990-04-25 Claude Piantadosi Derives d'ether ou d'ester lipidique contenant une amine quaternaire et composes therapeutiques
US5244913A (en) * 1991-11-19 1993-09-14 Baxter International Inc. Compositions and methods for dissolving body calculi
DE69431596D1 (de) * 1993-06-10 2002-11-28 Wake Forest University Winston (phospho)lipide zum bekämpfen einer hepatitis b-infektion
ATE395922T1 (de) * 1994-08-29 2008-06-15 Univ Wake Forest Lipid-analoge zur behandlung von viralen infektionen
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
KR20030041130A (ko) * 2001-05-29 2003-05-23 코닌클리케 필립스 일렉트로닉스 엔.브이. 금속-세라믹 접착
CN100469131C (zh) * 2001-08-31 2009-03-11 汤姆森许可公司 实现条件存取系统和传输、接收及处理内容的方法和设备
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
US20120058157A1 (en) * 2007-05-23 2012-03-08 Amcol International Corporation Methods of Treating Cardiovascular Disorders Associated with Atherosclerosis
US8481084B2 (en) * 2007-05-23 2013-07-09 Amcol International Corporation Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016209A (en) * 1975-04-23 1977-04-05 Merck & Co., Inc. 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2257173A1 (fr) * 2008-02-27 2010-12-08 Amcol International Corporation Procédés de traitement de troubles cardiovasculaires associés à une athérosclérose
EP2257173A4 (fr) * 2008-02-27 2011-08-31 Amcol International Corp Procédés de traitement de troubles cardiovasculaires associés à une athérosclérose

Also Published As

Publication number Publication date
FR2356425B1 (fr) 1978-12-15
BE856319A (fr) 1977-12-30
AU513829B2 (en) 1981-01-08
GB1564458A (en) 1980-04-10
ZA773747B (en) 1978-07-26
JPS536410A (en) 1978-01-20
AU2661577A (en) 1979-01-04
DE2729824A1 (de) 1978-01-05
US4096278A (en) 1978-06-20
CA1103154A (fr) 1981-06-16
NL7707263A (nl) 1978-01-03

Similar Documents

Publication Publication Date Title
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
FR2356425A1 (fr) Application a titre de medicaments de derives organiques de la montmorillonite
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
ES2170069T3 (es) 1-alfa-hidroxiprevitamina d para administracion oral.
FI941771A0 (fi) Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
IT1200178B (it) Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
SE8503664L (sv) Ett system for tillforsel av lekemedel
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
FR2362833A1 (fr) Nouveaux derives 5 de prostaglandine, leur procede de preparation et medicament les contenant
BE874416A (fr) Nouveaux derives de la benzene propanamine et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
AR033688A1 (es) Composicion parenteral reconstituible
DK0754034T3 (da) Brusende farmaceutiske formuleringer indeholdende biologisk nedbrydelige mikrokapsler med kontrolleret afgivelse
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
AR030039A1 (es) Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento
ATE173627T1 (de) Medizinische zusammensetzung
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
KR970025615A (ko) 암 전이 억제제
FR2554346B1 (fr) Ensemble et procede pour l'administration de gangliosides et de leurs derives par inhalation et compositions pharmaceutiques les contenant
BE906034A (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
BE827595A (fr) Medicament a administration par voie orale produisant un effet inhibiteur de l'antiplasmine

Legal Events

Date Code Title Description
ST Notification of lapse